The SYMMETRY Study

The SYMMETRY^SM Study - Clinical Trial for Metastatic Melanoma

Researchers are now enrolling patients with Stage IV metastatic melanoma for a clinical study evaluating an investigational drug for the treatment of melanoma.

What is the SYMMETRY^SM Study?

Melanoma is a form of skin cancer. According to the National Cancer Institute, melanoma is the most common form of cancer in the U.S. Melanoma can become dangerous when it spreads, or metastasizes, to other parts of the body.

Although there are medications available for treating late-stage melanoma, the options are limited. Currently, there are only two chemotherapy drugs approved by the United States Food and Drug Administration (FDA) for treating metastatic melanoma. Learn more>>

Interested in Participating?

Local doctors are now recruiting patients with metastatic melanoma to participate in the SYMMETRY^SM study. This medical research study is evaluating the safety and effectiveness of an investigational drug for the treatment of metastatic melanoma.

The investigational drug is being tested in combination with the chemotherapy drug paclitaxel.

To locate a clinic near you, pre-screen for the study, or request more information on participation, please call the SYMMETRY Study Call Center at 87-SYMMETRY (877-966-3879). The call center is open between the hours of 9am to 7pm, ET (6am to 4pm, PT), Monday through Friday.